Esketamine nasal and Insulin Glargine (U-300) Pens
Determining the interaction of Esketamine nasal and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: esketamine
Brand name: Spravato
Synonyms: Esketamine (nasal), Esketamine
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Esketamine nasal-Insulin glargine and lixisenatide
- Esketamine nasal-Insulin glargine and lixisenatide Subcutaneous
- Esketamine nasal-Insulin glargine, recombinant Subcutaneous
- Esketamine nasal-Insulin glulisine
- Esketamine nasal-Insulin Glulisine (Cartridges and Pens)
- Esketamine nasal-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Eslicarbazepine
- Insulin Glargine (U-300) Pens-Eslicarbazepine Acetate
- Insulin Glargine (U-300) Pens-Esmolol
- Insulin Glargine (U-300) Pens-Esmolol HCl
- Insulin Glargine (U-300) Pens-Esmolol Hydrochloride
- Insulin Glargine (U-300) Pens-Esmolol Injection